A cash-pay weight loss clinic running GLP-1 programs typically earns $150 to $500 per patient per month in margin, with a program of just 10 to 20 patients covering operating costs and larger panels becoming six-figure annual revenue streams from a single program. This guide breaks down the cash-pay weight loss clinic revenue model: per-patient margins by program, operating costs, staff time, and how the economics compare with insurance-based practice.
Revenue Per Patient by Program Type: What a Cash-Pay Weight Loss Clinic Can Earn
The revenue model is straightforward: the clinic charges a monthly program fee that covers medication, clinical oversight, and follow-up, then keeps the difference after wholesale pharmacy cost. Across typical US pricing, that difference is $150 to $350 per month for GLP-1 patients, $150 to $300 for peptide patients, and $100 to $200 for TRT patients.
The Med Spa Revenue Math: A 40-Patient Example
The fastest way to evaluate this model is with a concrete example. A med spa or weight loss clinic with 40 active GLP-1 patients at a $350 average monthly fee looks like this:
| Metric | Value |
|---|---|
| Active GLP-1 patients | 40 |
| Average monthly program fee | $350 |
| Monthly program revenue | $14,000 |
| Wholesale medication cost | ~$4,600 |
| Gross margin before operating costs | ~$9,400 |
| Platform fee, marketing, and admin | $1,500 to $2,000 |
| Estimated monthly net | $7,400 to $7,900 |
At that run rate, the program generates roughly $90,000 in annual net revenue on top of the clinic’s existing services. Scaling to 100 active GLP-1 patients pushes monthly net past $20,000, crossing six figures a year on this one program. And the entry math is forgiving: 10 to 20 patients produces $1,500 to $7,000 in monthly margin, enough to cover the monthly platform fee, marketing spend, and most overhead inside the first quarter.
GLP-1 Weight Loss Programs: $250 to $500 Per Month
GLP-1 programs command the highest per-patient revenue due to strong patient demand and high perceived value. The GLP-1 receptor agonist market has seen explosive growth, with IQVIA research tracking prescription volume increases exceeding 300% since 2020.
Typical pricing structure:
- Monthly program fee: $250 to $500
- Includes: compounded medication, clinical oversight, monthly check-in, dosing adjustments
- Some clinics charge a separate initiation fee of $100 to $200 for the initial consultation and lab review
Wholesale medication cost:
- Compounded semaglutide: $80 to $150 per month (varies by dose and pharmacy)
- Compounded tirzepatide: $100 to $200 per month (varies by dose and pharmacy)
Net margin per patient: $150 to $350 per month
Clinical time per patient: 5 to 15 minutes monthly (dose adjustments, check-ins)
At 50 active GLP-1 patients averaging $350 per month in program fees, a clinic generates $17,500 in monthly recurring revenue. After pharmacy costs of approximately $5,000 to $7,500, net program revenue is $10,000 to $12,500 monthly from this single program. For a detailed walkthrough of pricing, positioning, and patient acquisition, see our guide to selling GLP-1 programs. The full economics of the GLP-1 weight loss program are covered there and in the scenarios below.
Peptide Therapy Programs: $200 to $400 Per Month
Peptide therapy programs offer strong margins with excellent patient retention due to the ongoing nature of most protocols. The peptide therapy program works the same way: a monthly fee, wholesale cost, and a margin per patient.
Typical pricing structure:
- Monthly program fee: $200 to $400
- Varies by peptide protocol (single peptide vs. combination protocols)
- Premium protocols (multi-peptide stacks) can reach $500 to $800 monthly
Wholesale medication cost:
- Sermorelin: $30 to $60 per month (varies by dose)
- Multi-peptide protocols: $100 to $200 per month
Net margin per patient: $150 to $300 per month
Clinical time per patient: 5 to 10 minutes monthly
Peptide patients tend to have longer treatment durations than GLP-1 patients. Many remain on protocols for 6 to 12 months or cycle between protocols seasonally, creating strong lifetime value.
TRT Programs: $150 to $300 Per Month
Testosterone replacement therapy offers the highest patient lifetime value due to the indefinite treatment duration for most patients. The TRT program follows the same fee structure.
Typical pricing structure:
- Monthly program fee: $150 to $300
- Includes: testosterone compound, clinical monitoring, quarterly lab reviews
- Some clinics charge separately for labs ($50 to $100 quarterly)
Wholesale medication cost:
- Compounded testosterone (cypionate or enanthate): $30 to $60 per month
- Ancillary medications (anastrozole, HCG if included): $20 to $40 per month
Net margin per patient: $100 to $200 per month
Clinical time per patient: 5 to 10 minutes monthly, 15 to 20 minutes quarterly for lab review
TRT patients are the stickiest cohort in cash-pay medicine. According to research published in the Journal of Clinical Endocrinology & Metabolism, most TRT patients remain on therapy indefinitely once stabilized. A TRT patient acquired today may generate revenue for 5 to 10 years or longer. For a step-by-step approach to launching this program type, see our guide to starting a TRT clinic.
The Cash-Pay Model vs. Insurance-Based Revenue
Before deciding to add a cash-pay program, it helps to see why the model generates outsized returns relative to clinical time invested.
Insurance-Based Revenue Challenges
Traditional insurance-based practices face structural revenue constraints:
- Reimbursement rates are declining. Medicare and commercial payer reimbursements have not kept pace with practice costs. According to the American Medical Association, Medicare physician payment has declined approximately 26% in inflation-adjusted terms since 2001. The CMS Physician Fee Schedule continues to compress reimbursement rates year over year.
- Administrative overhead consumes revenue. Billing, coding, prior authorizations, claim denials, and appeals consume 15% to 25% of gross collections in most practices. A Medical Group Management Association (MGMA) benchmarking study found that administrative costs represent a growing share of practice expenses for insurance-dependent groups.
- Payment delays strain cash flow. Insurance reimbursement cycles of 30 to 90 days create cash flow gaps that require working capital.
- Volume requirements drive burnout. To maintain revenue targets, practices must see high patient volumes, leading to shorter visits and provider exhaustion.
Cash-Pay Revenue Advantages
Cash-pay specialty programs eliminate these constraints:
- You set the price. There are no fee schedules, negotiated rates, or annual reductions to work around.
- Payment is collected upfront. This eliminates claims, denials, and 90-day receivables from the operating picture.
- Administrative costs are minimal. Coding, billing, and prior authorization staff are not part of the model.
- Recurring revenue builds over time. Patients on monthly protocols generate predictable, compounding revenue.
- Higher revenue per clinical hour. Fewer patients produce more revenue with better care quality.
A Direct Comparison
Consider a family medicine practice generating $600,000 in annual revenue from insurance-based services:
| Metric | Insurance Model | Cash-Pay Model |
|---|---|---|
| Annual gross revenue | $600,000 | $500,000 |
| Billing and admin costs | $90,000 (15%) | $6,000 (1%) |
| Claim denials and write-offs | $60,000 (10%) | $0 |
| Staff for billing/coding | $55,000 | $0 |
| Net revenue after overhead | $395,000 | $494,000 |
| Patients required | 2,000+ per year | 135 active monthly |
| Clinical hours per week | 40+ | 15-20 |
| Payment timing | 30-90 days | Same day |
The cash-pay model generates comparable net revenue with a fraction of the patient volume and clinical time. Data from the HHS Office of the Assistant Secretary for Planning and Evaluation (ASPE) shows that administrative complexity in insurance-based medicine continues to rise, further widening the efficiency gap between cash-pay and traditional models. This is not an argument for abandoning insurance-based medicine entirely, but rather for adding cash-pay programs as a high-margin revenue layer.
Overhead and Operating Costs
Understanding the true cost structure is critical for accurate financial projections.
Platform and Technology Costs
Running a cash-pay specialty program requires infrastructure for patient signup, provider review, prescribing, pharmacy integration, and fulfillment tracking.
Options and their costs:
-
Turn-key platform (the Karpa Health model): A flat monthly platform fee that covers signup, provider review, prescribing workflows, pharmacy routing, and fulfillment tracking. This is the most cost-effective approach for clinics that want to launch in days rather than quarters.
-
Cobbled-together tools: $300 to $800 per month across multiple subscriptions (scheduling, e-prescribing, forms, and customer management tools). This approach requires more staff time to manage integrations and handoffs between systems.
-
Custom build: $10,000 to $50,000 upfront plus ongoing maintenance. Only justified at very high patient volumes (500+ patients).
Staff Time and Labor Costs
The biggest variable cost in any program is staff time per patient interaction.
Traditional (manual) workflow:
- Patient signup and form review: 15 to 20 minutes
- Provider review and chart documentation: 10 to 15 minutes
- Prescription writing and pharmacy communication: 5 to 10 minutes
- Follow-up scheduling and coordination: 5 to 10 minutes
- Total per new patient: 35 to 55 minutes
- Total per monthly follow-up: 15 to 25 minutes
Automated workflow (with automated screening and digital systems):
- Patient signup: automated (digital forms, self-service)
- Provider review: 3 to 5 minutes (automated pre-review with provider approval)
- Prescribing: 1 to 2 minutes (one-click prescribing)
- Follow-up: automated scheduling and check-in
- Total per new patient: 10 to 15 minutes
- Total per monthly follow-up: 3 to 7 minutes
The difference in staff time directly translates to capacity. A clinic using manual workflows might handle 30 to 50 cash-pay patients before needing additional staff. With automation, the same team can manage 150 to 300 patients.
Marketing and Patient Acquisition Costs
Patient acquisition costs vary widely by channel and market:
- Google Ads (search): $50 to $150 per acquired patient
- Social media advertising: $30 to $100 per acquired patient
- Referrals from existing patients: $0 to $25 per acquired patient (referral incentive)
- Content marketing and SEO: Low per-patient cost at scale, but requires 3 to 6 months to build
For most clinics, blended patient acquisition cost settles between $50 and $100 per patient. Given that patient lifetime value ranges from $1,800 to $6,000+ (depending on program and retention), the return on marketing spend is compelling. Research from the Physicians Foundation surveys shows that cash-pay and direct-pay models are growing across specialties as both physicians and patients seek alternatives to traditional insurance billing.
Building a Revenue Model: Example Scenarios
The scenarios below model the first year for a new clinic and for an established med spa. Both assume realistic pricing, wholesale costs, and acquisition pace. For the full playbook on the launch phase, see the GLP-1 weight loss business launch guide.
Scenario 1: New Clinic, First 90 Days
A clinic launches with GLP-1 and peptide programs:
- Month 1: 8 patients acquired (5 GLP-1, 3 peptide)
- Month 2: 15 cumulative patients (10 GLP-1, 5 peptide)
- Month 3: 25 cumulative patients (15 GLP-1, 10 peptide)
Month 3 revenue:
- 15 GLP-1 patients x $350 average = $5,250
- 10 peptide patients x $275 average = $2,750
- Total monthly revenue: $8,000
Month 3 costs:
- Pharmacy wholesale: $2,400
- Marketing: $1,000
- Total variable costs: $3,400
Net before platform fee: $4,600
After the flat monthly platform fee, the clinic clears roughly $4,000 per month by month 3. That is recurring revenue from just 25 patients, before referrals and word of mouth have had time to compound.
Scenario 2: Established Med Spa or Weight Loss Clinic, 12 Months In
A med spa running GLP-1, peptides, and TRT after one year:
- 60 GLP-1 patients x $375 average = $22,500
- 40 peptide patients x $300 average = $12,000
- 35 TRT patients x $200 average = $7,000
- Total monthly revenue: $41,500
Monthly costs:
- Pharmacy wholesale: $11,000
- Staff (one part-time coordinator): $2,500
- Marketing: $2,000
- Total variable costs: $15,500
Net before platform fee: $26,000
After the monthly platform fee, this works out to roughly $300,000 in annual net profit from programs that require approximately 15 to 20 hours of clinical time per week.
Key Metrics to Track
Clinics running successful cash-pay programs monitor these metrics:
Revenue Metrics
- Monthly recurring revenue (MRR): Total active patient revenue per month
- Average revenue per patient (ARPP): Total revenue divided by active patients
- Patient lifetime value (LTV): Average revenue generated over the full patient relationship
- Revenue per clinical hour: Total revenue divided by provider hours spent on the program
Operational Metrics
- Patient acquisition cost (CAC): Marketing spend divided by new patients acquired
- LTV to CAC ratio: Should be 10:1 or higher for cash-pay programs
- Churn rate: Percentage of patients discontinuing each month (target under 8%)
- Time to first prescription: Days from patient inquiry to first medication shipped
Margin Metrics
- Gross margin: Revenue minus pharmacy wholesale costs
- Net margin: Revenue minus all program-related costs
- Contribution margin per patient: Net revenue per patient after all variable costs
How Karpa Health Makes the Math Work
The revenue model is compelling, but execution complexity stops most clinics from launching. Managing signup, provider review, pharmacy coordination, and fulfillment across dozens or hundreds of patients requires infrastructure.
Karpa Health provides the operational backbone that turns these economics into monthly deposits:
- Staff time collapses. Signup and eligibility screening run on the platform, and provider review takes minutes instead of a full appointment block. The same team that handles 30 to 50 patients with manual workflows manages 150 to 300 on the platform.
- The patient relationship stays with your brand. The entire patient experience runs under your clinic’s name, so the recurring revenue and the patient list belong to your business. For a deeper look at owning the program, read our white-label GLP-1 brand guide.
- Fulfillment is handled. Prescriptions route to a licensed compounding pharmacy partner and patients receive their medication without staff chasing pharmacy calls.
- The revenue clock starts in days. A turn-key setup launches in days rather than the 60-plus days typical of building or integrating custom systems.
The platform transforms the cash-pay revenue model from theoretically attractive to operationally achievable, even for clinics without dedicated program staff.
Getting Started
For clinics evaluating a cash-pay weight loss program, the financial case is clear. These programs are profitable at small patient counts; the real constraint is how quickly you can build volume.
The clinics that succeed focus on three priorities:
- Launch quickly. Every month of delay is lost recurring revenue. Use a turn-key platform rather than spending months building custom systems.
- Start with one or two programs. Most clinics launch with GLP-1 weight loss, then add peptides or TRT once the workflow is established.
- Invest in patient acquisition. The economics reward scale. Allocate marketing budget from day one and track acquisition cost relative to patient lifetime value.
The cash-pay medication model represents one of the clearest opportunities in modern clinic economics. The clinics that move first will build patient bases and recurring revenue that compound over time.
For a look at the full cost picture of launching this type of program, read the telehealth clinic startup costs guide.
Book a call with Karpa Health if you want help structuring the right program.
